“Safety Assessment of Dose-Escalated 225Ac-PSMA-617 Radioligand Therapy in Patients with Advanced Metastatic Castration-Resistant Prostate Cancer Following Standard Treatment Failure”, Вопр. онкол., vol. 71, no. 5, p. OF-2520, Nov. 2025, doi: 10.37469/0507-3758-2025-71-5-OF-2520.